Showing results (31-40 of 50) with videos related to
Sort By:
Pageof 5
Cancer Discovery|July 26, 2019
The Mechanism of Anti-PD-L1 Antibody Efficacy against PD-L1-Negative Tumors Identifies NK Cells Expressing PD-L1 as a Cytolytic EffectorWenjuan Dong, Xiaojin Wu, Shoubao Ma, et al.Nature Immunology|April 29, 2022
ILC1s control leukemia stem cell fate and limit development of AMLZhenlong Li, Rui Ma, Shoubao Ma, et al.Oncotarget|December 20, 2017
High Tim-3 expression on AML blasts could enhance chemotherapy sensitivityLiangjing Xu, Jinge Xu, Shoubao Ma, et al.Cellular & Molecular Immunology|August 5, 2014
The S1P1 receptor-selective agonist CYM-5442 reduces the severity of acute GVHD by inhibiting macrophage recruitmentQiao Cheng, Shoubao Ma, Dandan Lin, et al.Nature Immunology|January 19, 2023
YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8<sup>+</sup> T cellsShoubao Ma, Baofa Sun, Songqi Duan, et al.Science Immunology|May 31, 2024
The tumor-intrinsic role of the m<sup>6</sup>A reader YTHDF2 in regulating immune evasionSai Xiao, Shoubao Ma, Baofa Sun, et al.Blood Advances|June 28, 2023
Off-the-shelf CAR-engineered natural killer cells targeting FLT3 enhance killing of acute myeloid leukemiaAnthony G Mansour, Kun-Yu Teng, Zhiyao Li, et al.Signal Transduction and Targeted Therapy|September 15, 2022
Dendritic cell-derived IL-27 p28 regulates T cell program in pathogenicity and alleviates acute graft-versus-host diseaseHuanle Gong, Shoubao Ma, Jia Chen, et al.JCI Insight|May 4, 2018
Prediction of acute GVHD and relapse by metabolic biomarkers after allogeneic hematopoietic stem cell transplantationXiaojin Wu, Yiyu Xie, Chang Wang, et al.Cancer Research|May 19, 2021
An Oncolytic Virus Expressing IL15/IL15Rα Combined with Off-the-Shelf EGFR-CAR NK Cells Targets GlioblastomaRui Ma, Ting Lu, Zhenlong Li, et al.Pageof 5